“This unit describes the use of cannabinoid radioligands in competitive binding assays for determining affinity parameters (IC50 , Ki ) of unlabeled compounds at transfected CB1 and CB2 receptors expressed in cell lines.”
www.thctotalhealthcare.com
“This unit describes the use of cannabinoid radioligands in competitive binding assays for determining affinity parameters (IC50 , Ki ) of unlabeled compounds at transfected CB1 and CB2 receptors expressed in cell lines.”